Cancel manufacturing licence of Marion biotech: Centre recommends Uttar Pradesh Drug Controller Authority

Published On 2023-03-06 06:45 GMT   |   Update On 2023-03-06 06:45 GMT
Advertisement

New DelhiThe Central government on Saturday recommended the Uttar Pradesh Drug Controller Authority to cancel the manufacturing licence of Marion biotech after 22 out of 36 samples taken for testing from it were found adulterated with Ethylene glycol, said Gautam Budh Nagar Drug inspector on Saturday.

According to Gautam Budh Nagar Drug inspector, Uttar Pradesh, "Centre recommends the State Drug Controller Authority to cancel manufacturing licence of Marion biotech after 22 out of 36 samples taken for testing from it were found adulterated with Ethylene glycol."
Advertisement
On March 4, Uttar Pradesh Drugs Controlling and Licensing Authority recommended the Centre regarding cancellation of the license after the company has been found using substandard syrups. The company Marion Biotech had supplied the cough syrups that reportedly caused the deaths of Children in Uzbekistan.
The Marion Biotech Pvt Ltd had come under the scanner in December last year for its cough syrup Dok-1 which is suspected to have led to the death of 18 children who consumed it in Uzbekistan after which the CDSCO launched a probe into the matter.
Earlier on Friday, the Noida Police arrested three people for the manufacture and sale of duplicate medicines who are linked with the pharmaceutical firm that manufactured cough syrup whose use is alleged to have led to the death some children in Uzbekistan last year. The case had been registered at Gautam Buddha Nagar Phase-3 Police Station under various sections of the Drugs and Cosmetics Act 1940.
A probe had been launched last year into the Noida-based drug manufacturer after the deaths of 18 children in Uzbekistan.
Tags:    
Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News